Home/Filings/4/0001437749-16-034194
4//SEC Filing

VIVEVE MEDICAL, INC. 4

Accession 0001437749-16-034194

CIK 0000879682operating

Filed

Jun 20, 8:00 PM ET

Accepted

Jun 21, 5:51 PM ET

Size

4.9 KB

Accession

0001437749-16-034194

Insider Transaction Report

Form 4
Period: 2016-06-17
Durbin Scott
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2016-06-17$5.00/sh+1,500$7,5006,568 total
Footnotes (2)
  • [F1]The reporting person purchased these shares in connection with the closing of a public offering of the Issuer's common stock (the "Offering") at the Offering price of $5.00 per share. The shares are subject to a lock-up provision for a period of 90 days following June 14, 2016, as required under a lock-up agreement with the underwriters of the Offering.
  • [F2]On April 15, 2016, the Issuer effected a 1-for-8 reverse stock split of its common stock (the "Split"), which began trading on a post-Split basis on April 18, 2016. The amount reported in Column 5 represents securities beneficially owned on a post-Split basis.

Issuer

VIVEVE MEDICAL, INC.

CIK 0000879682

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000879682

Filing Metadata

Form type
4
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 5:51 PM ET
Size
4.9 KB